Get our Free Patent Expiration, Litigation, and Drug Price Updates

Serving hundreds of leading biopharmaceutical companies globally:

Medtronic
McKinsey
McKesson
Baxter
Queensland Health
Colorcon

Generated: May 19, 2019

DrugPatentWatch Database Preview

Details for Patent: 7,316,997

« Back to Dashboard

Which drugs does patent 7,316,997 protect, and when does it expire?

Patent 7,316,997 protects EGRIFTA and is included in one NDA.

This patent has eighteen patent family members in eleven countries.

Summary for Patent: 7,316,997
Title:GH secretagogues and uses thereof
Abstract:The invention relates to use of a GH secretagogue (e.g. GRF or an analog thereof) for (1) altering a lipid parameter in a subject; (2) altering a body composition parameter in a subject, (3) treating a condition characterized by deficient or decreased bone formation in a subject (4) improving daytime vigilance and/or cognitive function in a subject, (5) improving a metabolic condition in a subject, (6) improving anabolism in a catabolic condition in a subject, and/or (7) improving and/or reconstituting immune function in a subject.
Inventor(s): Abribat; Thierry (St-Foy-les-Lyon, FR), De Villers; Andre (Outremont, CA), Allas; Soraya (Iles Des Soeurs, CA), Gravel; Denis (Saint-Lambert, CA), Chapdelaine; Alcide (Iles Des Soeurs, CA)
Assignee: Theratechnologies Inc. (Ville Saint-Laurent, CA)
Application Number:10/969,463
Prior Art and Litigation SupportOrder Prior Art and Litigation support for Patent 7,316,997
Patent Claim Types:
see list of patent claims
Use;

Drugs Protected by US Patent 7,316,997

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Theratechnologies EGRIFTA tesamorelin acetate POWDER;SUBCUTANEOUS 022505-001 Nov 10, 2010 RX Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial REDUCTION OF EXCESS ABDOMINAL FAT IN HIV-INFECTED PATIENTS WITH LIPODYSTROPHY ➤ Try a Free Trial
Theratechnologies EGRIFTA tesamorelin acetate POWDER;SUBCUTANEOUS 022505-002 Nov 29, 2011 RX Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial REDUCTION OF EXCESS ABDOMINAL FAT IN HIV-INFECTED PATIENTS WITH LIPODYSTROPHY ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate

Subscribe to access the full database, or try a Free Trial

International Family Members for US Patent 7,316,997

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Australia 2003229222 ➤ Try a Free Trial
Australia 2005297366 ➤ Try a Free Trial
Australia 2010200224 ➤ Try a Free Trial
Brazil PI0516935 ➤ Try a Free Trial
Canada 2485472 ➤ Try a Free Trial
Canada 2527039 ➤ Try a Free Trial
China 101084009 ➤ Try a Free Trial
Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration

Subscribe to access the full database, or try a Free Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Express Scripts
Healthtrust
Cipla
Cantor Fitzgerald
Chubb
Moodys

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.